about
In Vivo Anti-Candida Activity of Phenolic Extracts and Compounds: Future Perspectives Focusing on Effective Clinical InterventionsVulvovaginal candidiasis: Epidemiology, microbiology and risk factors.The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa.Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p.Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium.Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment.Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA).Candida albicans promotes invasion and colonisation of Candida glabrata in a reconstituted human vaginal epithelium.Novel strategies to fight Candida species infection.Candida tropicalis biofilm and human epithelium invasion is highly influenced by environmental pH.Participation of Candida albicans transcription factor RLM1 in cell wall biogenesis and virulenceThe CgHaa1-Regulon Mediates Response and Tolerance to Acetic Acid Stress in the Human Pathogen Candida glabrata.Insights into Candida tropicalis nosocomial infections and virulence factors.Candida glabrata: a review of its features and resistance.Bioactive properties and functional constituents of Hypericum androsaemum L.: A focus on the phenolic profile.The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.Propolis: a potential natural product to fight Candida species infections.Disinfectants to Fight Oral Candida Biofilms.Mechanical fatigue performance of PCL-chondroprogenitor constructs after cell culture under bioreactor mechanical stimulus.Portrait of Candida Species Biofilm Regulatory Network Genes.Antifungal activity of phenolic compounds identified in flowers from North Eastern Portugal against Candida species.Candida tropicalis biofilms: effect on urinary epithelial cells.An in vitro evaluation of Candida tropicalis infectivity using human cell monolayers.Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata.Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production.Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment.Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate.Detection and quantification of fluconazole within Candida glabrata biofilms.Effect of progesterone on Candida albicans vaginal pathogenicity.Evaluation of the ability of C. albicans to form biofilm in the presence of phage-resistant phenotypes of P. aeruginosa.In vitro biofilm activity of non-Candida albicans Candida species.Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression.Silver colloidal nanoparticles: effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms.Adhesion of Candida biofilm cells to human epithelial cells and polystyrene after treatment with silver nanoparticles.Decoction, infusion and hydroalcoholic extract of cultivated thyme: antioxidant and antibacterial activities, and phenolic characterisation.Antibiofilm activity of propolis extract on Fusarium species from onychomycosis.Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.The carboxylic acid transporters Jen1 and Jen2 affect the architecture and fluconazole susceptibility of Candida albicans biofilm in the presence of lactate.Candida glabrata Biofilms: How Far Have We Come?Candida Species Biofilms' Antifungal Resistance.
P50
Q26783986-4D24DF64-FE46-4454-A08A-1EB544FDFC8BQ30251998-5AF1FF05-48E1-4C8E-A358-FF4BB9C4754FQ33574052-1F465750-3943-4F2F-A835-6B3F315030AFQ33693252-AE34FCB4-FE1D-4DA5-AB3C-AE54103B7C98Q33772099-9F4F1707-CE38-4CB2-9870-8709DC03AA94Q34418447-0B0D8398-2A80-46B9-9ABC-008DB3D23552Q34471793-0A3ED68B-27B5-49D5-B708-124D4266C574Q35187195-D80EC738-4491-4CEF-AC4B-2357303EEFAAQ35406737-C431217E-51D0-4B12-8637-304A5D9F87BDQ36153026-CC547463-D051-4931-A82E-EC991B6C405CQ37510027-4F190068-231D-43A6-8CE9-7794D28022B6Q37565696-89A9B31E-C519-442A-9508-15C8FC803486Q37950850-7DAC5C3A-52DB-4126-9FF4-9CE68AF3AC35Q38163927-285C56DD-EBBB-46FD-B4EB-8C6CD9DAC3B7Q38688854-D5E7CED9-132B-485B-A371-47FE7AEAF642Q38691273-AE823A47-B22F-4031-A977-18F44CC84918Q38833403-7FBF358D-5622-4B75-B193-47D5561655DEQ38857865-7B8A90B4-ADFF-4946-A4EA-AAF094A968F0Q38899830-CEBAF493-CAFB-4F06-97B1-1A59077C543BQ38975379-0BD5E898-1A7C-4ADD-8A1C-2BB826179AADQ39244568-2F27666B-0051-415E-80D5-48C795E36F31Q39342765-D4A318EF-C41A-4692-B1DA-7258DB96A8A1Q39544035-9E4DDA50-E6C2-45EF-A0DA-8D21DAA88717Q39728831-F2547B18-31ED-4164-AC70-E51986D06186Q40318343-F85D2248-6FC6-4EE9-B9E7-2E1916BE7306Q40646727-AC1D23C4-CCBD-4854-B5E0-6D6DBD6640CAQ40990150-20632E3B-3387-42F9-9897-BE344E0D8116Q41526027-3FA0BD68-08E6-4FDB-BCAA-B1C9580C89FEQ41756749-766A467B-B5F5-49AB-9FDC-5A04E17E8B71Q42267357-60794C33-F1B8-4D8E-970F-B74732375F0FQ43094518-D22A73D9-977D-479F-A851-0B38C8A5874EQ43750492-A4B3635A-3E92-431C-BA2D-876DD0C5256FQ44019485-F82C240B-9FDA-499C-947A-BC22B1CACA45Q44729686-2EA93176-ACE8-402E-B6AF-EA25269ADED1Q44862740-C8919633-D8F2-4687-99A3-2DFAD4260F25Q46295366-4DE9FD26-98F4-47AF-A23D-5D9D207A5CF0Q46699905-EEB29F6A-2AD4-441F-A223-1C109D07EBC9Q47388949-4462CC6F-C2CA-4510-94F8-C99FFB3F2DA3Q48163274-9EB93E51-17C7-4C63-96C1-1017C3852C8EQ48163282-4C1DF2E3-9E57-48B6-B74D-63E579C6B5D5
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0003-0000-7387
@en
name
Sónia Silva
@ast
Sónia Silva
@en
Sónia Silva
@es
Sónia Silva
@nl
type
label
Sónia Silva
@ast
Sónia Silva
@en
Sónia Silva
@es
Sónia Silva
@nl
altLabel
S Silva
@en
prefLabel
Sónia Silva
@ast
Sónia Silva
@en
Sónia Silva
@es
Sónia Silva
@nl
P1053
F-1190-2013
P106
P1153
35307858400
56572012200
P31
P496
0000-0003-0000-7387